| ¿µ¹® | irritation, stimulus | ÇÑ±Û | ÀÚ±Ø |
|---|---|---|---|
| ¼³¸í | »ý¹°¿¡ ÀÛ¿ëÇÏ¿© ƯÁ¤ÀÇ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ¿äÀÎ. º¸Åë ¿Ü°èÀÇ Á¶°Ç º¯È¿¡ µû¶ó »ý¹°Ã¼¿¡ ƯÀ¯ÇÑ È°µ¿ÀÌ ¿Õ¼ºÇØÁö´Â °ÍÀ» »ý¹°Ã¼°¡ ÈïºÐÇß´Ù°í Çϸç, ÈïºÐÀ» ÀÏÀ¸Å°´Â ¿øÀÎÀÌ µÈ ¿Ü°èÀÇ Á¶°Ç º¯È¸¦ ÀÚ±ØÀ̶ó°í ÇÑ´Ù. ¿¹¸¦ µé¸é, ¹Ù´Ã ³¡À¸·Î ¼ÕµîÀ» Â¸é ½Å°æ¼¶À¯¿¡ ÀÚ±ØÀ» ÁÖ°Ô µÇ¾î, ÀÌ ½Å°æ¼¶À¯¿¡ Ãæ°ÝÀ̶ó°í ÇÏ´Â ¾î¶² º¯È°¡ »ý±ä´Ù. ÀÌ Ãæ°ÝÀÌ ÀüµµµÇ¾î °£´Ù. ÀÌ »óŸ¦ ½Å°æ¼¶À¯°¡ ÈïºÐÇß´Ù°í ÇÑ´Ù. ¿ÜÀûÁ¶°ÇÀÇ º¯È°¡ À̰Ϳ¡ ´ëÀÀÇÏ´Â °¨°¢±â°¡ ¼ö¿ëÇÏ¿© ÀÚ±ØÀÌ µÇ´Âµ¥, Àڱؿ¡ ´ëÇÑ ¹ÝÀÀ¿¡ ¹Ý»çÀûÀ¸·Î ÀϾ´Â ´«±ô¹ÚÀÌ¿Í °°Àº ±¹ºÎÀûÀÎ °ÍÀÌ ÀÖ°í, ±â¿ÂÀÇ º¯È¿¡ ´ëÇØ¼¿Í °°ÀÌ Àü½ÅÀûÀÎ °Íµµ ÀÖ´Ù. ¼¼Æ÷ÀÚ±ØÀ¸·Î¼ ÀÛ¿ëÇÏ´Â ¿Ü°èÀÇ Á¶°Ç º¯È´Â ±× ¿¡³ÊÁöÀÇ Á¾·ù¿¡ µû¶ó ±â°èÀû ÀÚ±Ø-ÈÇÐÀû ÀÚ±Ø-¿Â¿Àû ÀÚ±Ø-»ïÅõ¾Ð ÀÚ±Ø-Àü±âÀû ÀÚ±Ø µîÀÌ ÀÖ´Ù. ±× Áß Àü±âÀû ÀÚ±ØÀº »ýü ¼Ó¿¡¼ ÀÚ¿¬È÷ ÀϾ´Â Àڱذú ±×·Î ÀÎÇØ ÀϾ´Â ÈïºÐÀÌ ¸ðµÎ Àü±âÀû °úÁ¤À̹ǷΠÀÚ¿¬È÷ ÀϾ´Â Àڱذú °°°Å³ª, ±×°Í¿¡ °¡±î¿î °ÍÀÌ´Ù. ¾î¶² Á¾·ùÀÇ Á¶°Ç º¯È´Â µµ¸®¾î ÈïºÐÀ» ÀÏÀ¸Å°±â ¾î·Æ°Ô ÇÏ´Â °Íµµ ÀÖ´Ù. |
||
| RS | radioscaphoid; random sample; rating schedule; Raynaud syndrome; recipient's serum; rectal sinus; re... |
|---|---|
| CCF | 1) Carotid(Carotico-) Cavernous Fistula 2) Crystal-induced Chemotactic Fa... |
| BCF | basophil chemotactic factor; bioconcentration factor; breast cyst fluid |
| BST | bacteriuria screening test; blood serologic test; brief stimulus therapy |
| CA | anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can... |
| C.I. | Chemotactic Index |
|---|---|
| chemokines | Chemotactic cytokines |
| CF | Chemotactic factor |
| CFI | Chemotactic factor inactivator |
| ECA | Eosinophil chemotactic activity |
| chemotactic | A response of motile cells or organisms in which the direction of movement is affected by the gradient of a diffusible substance. Differs from chemokinesis in that the gradient alters probability of motion in one direction only, rather than rate or frequency of random motion. (18 Nov 1997) |
|---|---|
| chemotactic factors | Chemical substances that attract or repel cells or organisms. The concept denotes especially those factors released as a result of tissue injury, invasion, or immunologic activity, that attract leukocytes, macrophages, or other cells to the site of infection or insult. (12 Dec 1998) |
| chemotactic factors, eosinophil | Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ecf-a, released mainly by mast cells. (12 Dec 1998) |
| chemotactic factors, macrophage | Cytotaxins liberated from normal or invading cells that specifically attract macrophages. They may be lymphokines, products of antigen, antibody and complement interactions or other. (12 Dec 1998) |
| chemotactic protein methylesterase | <enzyme> Demethylates methyl-accepting chemotaxis proteins Registry number: EC 3.1.1.- Synonym: chemotactic methylesterase, carboxymethylesterase of chemotaxis, cheb methylesterase (26 Jun 1999) |
| monocyte chemotactic and activating factor | Cytokine of the C C subfamily, co induced with IL-8 on stimulation of endothelial cells, fibroblasts or monocytes that activates and is chemotactic for, monocytes. A chemokine. (18 Nov 1997) |
| monocyte derived neutrophil chemotactic factor | <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Acronym: IL-8 (12 Dec 1998) |
| complement chemotactic factor | The activated complex of the fifth, sixth, and seventh components of complement (C567) which induces chemotaxis in the case of polymorphonuclear leukocytes. (05 Mar 2000) |
| eosinophil chemotactic factor of anaphylaxis | A peptide (MW 500 to 600) that is chemotactic for eosinophilic leukocytes and is released from disrupted mast cells. (05 Mar 2000) |
| eosinophil chemotactic peptide | <protein> Tetrapeptides (of which two are identified: VGSE and AGSE) released by mast cells and that are said to both attract and activate eosinophils. (18 Nov 1997) |
| adequate stimulus | A stimulus to which a particular receptor responds effectively and that gives rise to a characteristic sensation; e.g., light and sound waves that stimulate, respectively, visual and auditory receptors. (05 Mar 2000) |
| aversive stimulus | <psychology> A noxious stimulus such as an electric shock used in aversive training or conditioning. See: aversive training. (05 Mar 2000) |
| maximal stimulus | A stimulus strong enough to evoke a maximal response. (05 Mar 2000) |
| conditioned stimulus | A stimulus applied to one of the sense organs (e.g., receptors of vision, hearing, touch) which are an essential and integral part of the neural mechanism underlying a conditioned reflex. See: classical conditioning, higher order conditioning. (05 Mar 2000) |
| heterologous stimulus | A stimulus that acts upon any part of the sensory apparatus or nerve tract. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|